Add BrightSurf on Google Email

Feed a virus, starve a bacterial infection?

A new study published in Cell found that providing nutrients to mice with viral infections can help them survive, while those with bacterial infections die when fed. The researchers discovered that the brain's metabolic needs differ depending on the type of infection, which may have implications for designing clinical trials.

SourceCell Press·JournalCell·DateSep 8, 2016

New hope for shock patients in intensive care

A new medical device that combines laser spectroscopy and precise flow measurement has shown promise in improving care for shock patients. The device, which fits into a standard ventilation tube, allows doctors to monitor oxygen consumption in real-time, potentially leading to more effective treatment.

SourceUniversity of Oxford·JournalScience Advances·DateAug 10, 2016

Teaming up against sepsis

A multidisciplinary team of UCSB faculty members and clinicians will conduct biomedical research on sepsis, a severe response to infections, thanks to a $12.8 million NIH grant. The program aims to develop radically different approaches to treating sepsis, with the goal of reducing disability and death.

Wyss Institute to lead project to uncover underlying causes of tolerance to infection

The Wyss Institute aims to discover why some individuals tolerate infectious pathogens while others exhibit life-threatening responses, which could inform the development of novel therapies. The project will search for and identify examples of tolerance across several species through experiments with clinically-relevant pathogens.

Protein patterns -- a new tool for studying sepsis

A new method using mass spectrometry measures hundreds of proteins in a single blood sample, enabling researchers to determine the severity of sepsis and which organs are damaged. This technique provides an understanding of molecular events during the course of a disease, with potential applications for studying other diseases.

SourceLund University·JournalNature Communications·DateJan 13, 2016

Rapid molecular assay may help diagnose sepsis

A rapid molecular assay using RNA biomarkers in blood can differentiate sepsis from infection-negative systemic inflammation more accurately and quickly than traditional methods. The assay, known as SeptiCyte Lab, was validated in independent cohorts and showed high sensitivity and specificity.

SourcePLOS·JournalPLOS Medicine·DateDec 8, 2015

Advances made against the deadly infection complication, sepsis

A hospital surveillance program utilizing a two-stage Clinical Decision Support (CDS) system reduced the risk of adverse outcomes, such as death and hospice discharge for sepsis patients, by 30%. The study found that 61% of patients who first activated the alert had SIRS syndrome, an early physiologic response to infection.

SourceSAGE·JournalAmerican Journal of Medical Quality·DateOct 21, 2015

Queen's University developing new drug against leading causes of death -- sepsis and ARDS

Scientists at Queen's University Belfast have developed a novel anti-inflammatory nanoparticle that shows promise in treating sepsis and Acute Respiratory Distress Syndrome (ARDS), two leading causes of death in hospitalised patients. The treatment, known as SAN101, has the potential to reduce inflammation and prevent organ failure.

SourceQueen's University Belfast·JournalScience Translational Medicine·DateSep 2, 2015

Hospital readmissions for sepsis are highly common, extremely costly

A new UCLA study found that sepsis accounts for a significant percentage of hospital readmissions in California, with an estimated annual cost of $500 million. The study also revealed disparities in readmission rates among different demographics, highlighting the need for targeted interventions to address this critical issue.

Gut check: Does a hospital stay set patients up for sepsis by disrupting the microbiome?

A new University of Michigan and VA study suggests that hospital stays can increase the risk of sepsis in older adults by disrupting their gut microbiome. The research found that older adults are three times more likely to develop sepsis within 90 days of hospitalization, especially after care that alters the balance of microbes.

SourceMichigan Medicine - University of Michigan·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJun 1, 2015

The Lancet Infectious Diseases: Leading doctors warn that sepsis deaths will not be curbed without radical rethink of research strategy

Sepsis, a life-threatening condition causing widespread inflammation and organ failure, is poorly understood despite being one of the best-known medical disorders. The Lancet Infectious Diseases Commission recommends prioritizing biomarkers, education, and public awareness to improve diagnosis and treatment.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateApr 19, 2015

Review of global guidelines for sepsis needed

A Monash University study reviewed over a million ICU patients in Australia and New Zealand, finding one in eight did not meet current sepsis criteria. The classic definition of sepsis may be missing critically ill patients, particularly the elderly or those on medications that affect heart rate or immune systems.

SourceMonash University·JournalNew England Journal of Medicine·DateMar 20, 2015

Rapid test to diagnose severe sepsis

A new rapid test developed by University of British Columbia researchers can predict severe sepsis within an hour, allowing timely treatment to begin. The genetic signature associated with the disease has been identified and can be tested as soon as a patient arrives in the emergency ward.

SourceUniversity of British Columbia·JournalEBioMedicine·DateOct 22, 2014

A novel therapy for sepsis?

Researchers at the University of Tokyo have found that PTX3, a protein involved in innate immunity, can reduce mortality from sepsis by protecting endothelial cells from damage. The study's findings suggest that PTX3 may be used to develop a novel therapy for sepsis.

SourceUniversity of Tokyo·JournalScience Signaling·DateSep 16, 2014

Penn study: Sepsis patients fare better in hospitals with higher case volumes

A new study from Penn Medicine found that patients with sepsis who are treated at high-volume hospitals have a 36% increase in their odds of inpatient survival compared to those treated at lower-volume hospitals. The study suggests that regionalized severe sepsis care centers may improve outcomes for critically ill patients.

SourceUniversity of Pennsylvania School of Medicine·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateSep 3, 2014

Sepsis involved in high percentage of hospital deaths

A study published in JAMA found that sepsis is a major contributor to hospital mortality, with approximately 1 in 2 to 3 deaths attributed to the condition. Most patients who died from sepsis had the condition present at admission. The study highlights the need for improved standardized care for patients with less severe sepsis.

SourceJAMA Network·JournalJAMA·DateMay 18, 2014